Newsroom
Placeholder

TriCore Announces Steve Ayer as Chief Information Officer

05/25/2018

TriCore Announces Steve Ayer as Chief Information Officer

Read More
Placeholder

TriCore Announces Renee Ennis as Chief Financial Officer

03/21/2018

TriCore Reference Laboratories is pleased to announce Renee Ennis as Chief Financial Officer, effective April 23, 2018.

Read More
Placeholder

TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President

03/15/2018

TriCore Announces Dr. Michael Crossey as Chief Executive Officer and President

Read More
Placeholder

Helping Medical Laboratories Add Value to Health Systems, Providers, and Payers by Moving from Clinical Lab 1.0 to Clinical Lab 2.0

12/01/2017

Read More
Placeholder

Dr. Nick Dayan, CAO of TriCore Reference Laboratories, named chair and Mark Fidel, co-founder of RiskSense, named vice-Chair of March for Babies

10/16/2017

Dr. Nick Dayan, CAO of TriCore Reference Laboratories, named chair and Mark Fidel, co-founder of RiskSense, named vice-Chair of March for Babies

Read More
Placeholder

TriCore's First Chief Scientific Officer

08/14/2017

Albuquerque-based TriCore Reference Laboratories has established a new executive role to focus on research, the company announced.

Read More
Placeholder

Defenders of Health Campaign

06/19/2017

TriCore Launches Defenders of Health Statewide Ad Campaign

Read More
Placeholder

Lovelace Health System Selects TriCore

10/31/2016

ALBUQUERQUE (October 31, 2016) – Lovelace Health System announced today that it has selected TriCore Reference Laboratories (TriCore) for inpatient and outpatient laboratory management services at its Albuquerque hospitals.

Read More
Placeholder

Paving the way to integrate two of healthcare's crucial services

08/17/2016

TriCore is joining forces with the University of New Mexico’s (UNM) College of Pharmacy, creating a unique opportunity for pharmacists & laboratorians to partner in the laboratory environment to improve patient outcomes.

Read More
Placeholder

Systemic Mastocytosis Responds to New Drug

07/01/2016

A drug called midostaurin showed promise in an international clinical trial coauthored by University of New Mexico and TriCore Reference Laboratories’ pathologist, Tracy George, MD.

Read More

TriCore in the News

3 New Mexicans to know who will make you feel badly about yourself

Here are three New Mexicans to know, at different stages of their careers, who not only make me feel badly about myself but also great pride that this is my community and these are the kinds of people I am privileged to work among

Albuquerque Business First,03/28/2018

Healthiest Employers: This leading health care company spends big on employee wellness

TriCore Reference Laboratories honored as one of 18 companies in New Mexico that have succeeded in creating healthy workplaces for their employees.

Albuquerque Business First,02/27/2018

With technology developed by TGen, the test allows for rapid definitive diagnosis of Valley Fever

DxNA LLC, a molecular diagnostics
company, today announced the regulatory clearance by the U.S. Food and Drug
Administration (FDA) to market its molecular test for rapid detection of
Coccidioidomycosis (Valley Fever) using DxNA’s GeneSTAT.MDx Coccidioides
test and proprietary GeneSTAT System.

www.dxna.com,12/11/2017

American Healthcare Leader - Switching Gears

World-class cyclist Dina Hannah goes the extra mile inside and out of the office at TriCore Reference Laboratories.

American Healthcare Leader,10/02/2017

View All

Recent Tweets

Follow us on Twitter

Contact Us

Beth Bailey
beth.bailey@tricore.org